Older Age Significantly Affects Mortality of Patients with Papillary Thyroid Carcinoma Only When They Have High-Risk Features

被引:4
作者
Ito, Yasuhiro [1 ]
Miyauchi, Akira [1 ]
Higashiyama, Takuya [1 ]
Masuoka, Hiroo [1 ]
Kihara, Minoru [1 ]
Miya, Akihiro [1 ]
机构
[1] Kuma Hosp, Dept Surg, Chuo Ku, 8-2-35 Shimoyamate Dori, Kobe, Hyogo 6500011, Japan
关键词
CANCER;
D O I
10.1007/s00268-020-05429-x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Old age is a known prognostic factor for mortality in patients with papillary thyroid carcinoma (PTC). This study aimed to investigate the relationship between cause-specific survival (CSS) following PTC and the extent of old age. Methods We enrolled 4692 patients aged >= 55 years with PTC who underwent surgery between 1989 and 2009 at Kuma Hospital (median follow-up period 140 months). The presence of at least one of the following was used to classify the patients as high risk: (1) tumor sizes > 4 cm, (2) node metastasis >= 3 cm, (3) significant extrathyroid extension corresponding to T4a, (4) extranodal tumor extension, and (5) distant metastasis. T1N0M0 PTC was classified as low risk, and all other patients were classified as intermediate risk. We divided all patients into three categories based on age: 55-64, 65-74, and >= 75 years. Results One low-risk patient (0.04%), 18 intermediate-risk patients (1.5%), and 105 high-risk patients (9.4%) died of PTC, and CSS of high-risk patients was poorer than that of others (p < 0.0001). The CSS of low and intermediate-risk patients did not differ with age. However, CSS of high-risk patients became significantly poorer with advancing age (p = 0.0017 for 55-64 years vs. 65-74 years, and p = 0.0109 for 65-74 years vs. >= 75 years). Conclusions Advanced age has a significant prognostic impact on CSS only for high-risk patients with PTC.
引用
收藏
页码:1885 / 1891
页数:7
相关论文
共 45 条
  • [21] Prognostic significance of inflammatory markers LMR, PLR, MPV, FIB in intermediate-and high-risk papillary thyroid carcinoma
    Li, Canxiao
    Li, Jingting
    Li, Shijie
    Zhao, Yishen
    Liu, Guandong
    Du, Rui
    Dionigi, Gianlorenzo
    Liang, Nan
    Sun, Hui
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [22] The significance of unrecognized histological high-risk features on response to therapy in papillary thyroid carcinoma measuring 1-4 cm: implications for completion thyroidectomy following lobectomy
    Lang, Brian H. -H.
    Shek, Tony W. H.
    Wan, Koon Y.
    CLINICAL ENDOCRINOLOGY, 2017, 86 (02) : 236 - 242
  • [23] Predictors of recurrence after total thyroidectomy plus neck dissection and radioactive iodine ablation for high-risk papillary thyroid carcinoma
    Kim, Yonghan
    Roh, Jong-Lyel
    Song, Dongeun
    Cho, Kyung-Ja
    Choi, Seung-Ho
    Nam, Soon Yuhl
    Kim, Sang Yoon
    JOURNAL OF SURGICAL ONCOLOGY, 2020, 122 (05) : 906 - 913
  • [24] Prognostic biomarkers for predicting papillary thyroid carcinoma patients at high risk using nine genes of apoptotic pathway
    Arora, Chakit
    Kaur, Dilraj
    Naorem, Leimarembi Devi
    Raghava, Gajendra P. S.
    PLOS ONE, 2021, 16 (11):
  • [25] Risk factors associated with high-risk nodal disease in patients considered for active surveillance of papillary thyroid microcarcinoma without extrathyroidal extension
    Kwon, Ohjoon
    Lee, Sohee
    Bae, Ja Seong
    GLAND SURGERY, 2023, 12 (09) : 1179 - 1190
  • [26] ?Micro? Extrathyroidal Extension in Risk Stratification for Papillary Thyroid Carcinoma: Should It Be in the Intermediate-Risk or High-Risk Group? A Single-Center Retrospective Study
    He, Qi
    Ji, Feihong
    Fu, Xinghao
    Li, Zehao
    Qiu, Xinguang
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 3181 - 3190
  • [27] Lobectomy is a more Cost-Effective Option than Total Thyroidectomy for 1 to 4 cm Papillary Thyroid Carcinoma that do not Possess Clinically Recognizable High-Risk Features
    Lang, Brian Hung-Hin
    Wong, Carlos K. H.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (11) : 3641 - 3652
  • [28] Clinicopathological and ultrasound features as risk stratification predictors of clinical and pathological nodal status in papillary thyroid carcinoma: a study of 748 patients
    Zhang, Cui
    Li, Baojun
    Zhang, Lei
    Chen, Fengjiao
    Zhang, Yanhua
    Cheng, Wen
    BMC CANCER, 2022, 22 (01)
  • [29] A-kinase interacting protein 1 as a potential biomarker of advanced tumor features and increased recurrence risk in papillary thyroid carcinoma patients
    Zhang, Luqing
    Tao, Haiying
    Ke, Kongliang
    Ma, Cui
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2020, 34 (10)
  • [30] Targeting Diagnosis of High-Risk Papillary Thyroid Carcinoma Using Ultrasound Contrast Agent With the BRAFV600E Mutation An Experimental Study
    Xie, Fang
    Yan, Lin
    Li, Yi-Ming
    Lan, Yu
    Xiao, Jing
    Zhang, Ming-Bo
    Jin, Zhuang
    Zhang, Ying
    Tian, Xiao-Qi
    Zhu, Ya-Qiong
    Li, Zhi-Ping
    Luo, Yu-Kun
    JOURNAL OF ULTRASOUND IN MEDICINE, 2022, 41 (11) : 2789 - 2802